Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

New Assays May Help in the Diagnosis & Management of Antiphospholipid Syndrome

  |  

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

Reference

ADVERTISEMENT
SCROLL TO CONTINUE
  1. Pericleous C, Ferreira I, Borghi O, et al. Measuring IgA anti-β2-glycoprotein I and IgG/IgA anti-domain I antibodies adds value to current serological assays for the antiphospholipid syndrome. PLoS One. 2016 Jun 2;11(6):e0156407. doi: 10.1371/journal.pone.0156407. eCollection 2016.

Related Articles

    APS: What Rheumatologists Should Know about Hughes Syndrome

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…